BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 12 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 12 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 12 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 13 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 13 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 14 hours ago Atmus Welcomes Heath Sharp to Board of Directors 16 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 16 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 12 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 12 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 12 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 13 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 13 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 14 hours ago Atmus Welcomes Heath Sharp to Board of Directors 16 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 16 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago
ADVERTISEMENT

Diebold Inc. (NYSE: DBD) Q4 2019 Earnings Call Transcript

Diebold Inc. (DBD) Q4 2019 earnings call dated Feb. 11, 2020 Corporate Participants: Steve Virostek — Investor Relations Gerrard Schmid — President and Chief Executive Officer Jeffrey Rutherford — Senior Vice…

Market News

Diebold (NYSE: DBD): Q4 2019 Earnings Snapshot

— Diebold Nixdorf (NYSE: DBD) reported its fourth-quarter 2019 adjusted earnings of $0.47 per share versus $0.50 per share expected. — Total net sales declined…